AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

Delivering the Latest Research and Best Practices from Around the World

AsiaTides 2010(寡核酸與肽治療診斷相關研討會)

2010年2月22日-24日,日本東京 Sheraton Miyako Hotel

Event Overview

有關新產品的開發與產品線的擴充，對於利用RNA干擾(RNAi)、適體、微型DNA、寡核苷酸、縮氨酸的治療法的研究是不可或缺的

Choose your language

Delivering the Latest Research and Best Practices from Around the World

Conference Tutorials:

Analysis and Bioanalysis of Oligonucleotides in Support of Drug Development
RNA/DNA Synthesis and Purification: From Research to Commercial Scale

Conference Sessions:

RNAi Lead Generation and Preclinical Development
Updates on Oligo-Based Therapeutics in Clinical and Preclinical Development
Peptide-Based Therapeutics in Preclinical and Clinical Development
Peptide Vaccines
Diagnostics in Development
Delivery: Challenges and Solutions for Oligo and Peptide Therapeutics
Market Landscape: Intellectual Property
Innovation Showcase
Regulatory Updates

Network with Event More Colleagues:

Co-located with:

Innovation in Japan - Is It Still Alive?
Next Generation Biologics
Personalized Medicine and Biomarker Strategies in Drug Development
Developments in Stem Cell Science and Therapeutic Applications
Molecularly Targeted Cancer Therapies as a New Paradigm in Cancer Drug Development

» More information on this event

Network with Event More Colleagues:

Tides 2010

2010年4月25～28日
麻塞諸塞州波士頓

» More information on this event

AsiaTIDES是在日本運用寡核苷酸與縮氨酸之治療法與診斷法的領域中唯一將焦點集中在研究、技術/製品開發、製造、合作上的學術會議。
在會期中，將有來自世界各地最尖端研究機構的研究人員，針對藥物遞送及處方的新方法、目前開發中的化合物、從製藥業界與學術研究機關雙方的觀點來看商業化之最有效策略等主題發表最新的研究成果。

將有助於今後的研究開發：
RNA及縮氨酸關連的最新技術
• 將有來自北美與歐洲的領導尖端科技企業代表人前來發表有關藥物遞送與處方的新方法

將有助於研究開發之確切評估：
RNA及縮氨酸醫藥的最新情報
• 藉由聆聽來自北美的37位演講者與來自歐洲的7位演講者的演講，將能夠掌握其他企業的動向，從各種個案研究與成功案例中學得教訓

有助於發展開發計畫、擴充知識：
RNA及縮氨酸醫藥的市場性與企業間的合作聯盟
• 可參加探討世界各國推行中的法規的未來進展、市場的展望、合作構想等主題的會議時段。

Keynote Presentations:

Synthesis and Biological Activity of the Nucleic Acids and Their Analogs
Marvin H. Caruthers, Ph.D., Distinguished Professor Chemistry and Biochemistry, University of Colorado, USA

Therapeutic Applications of Dicer Substrate siRNAs
John J. Rossi, Ph.D., Chairman, Lidow Family Endowed Research, Professor, Molecular Biology, Beckman Research Institute of City of Hope, USA
Presentation supported by Dicerna Pharmaceuticals

Defying Difficult Diseases: Biomolecule-based Medicinal Science
Yoshiaki Kiso, Ph.D., Professor & Chairman Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Japan

RNAi and Peptide Intellectual Property Landscapes: Early and Evolving
Kathleen M. Williams, Ph.D., J.D. Partner, Intellectual Property Law, Edwards Angell Palmer & Dodge LLP, USA